Myriad Genetics (MYGN) Gross Profit Growth (1y) (2010 - 2026)
Myriad Genetics (MYGN) Gross Profit Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 9.56% |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | 2.50% |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 12.14% |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 14.32% |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | 8.47% |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | 119.42% |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | 10.79% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | 12.13% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 8.91% |
| 10 | Myriad Genetics | 296.09 Mn | 171.69 Mn | 137.60 Mn | 2.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.53% |
| Dec 31, 2025 | -2.72% |
| Sep 30, 2025 | -4.01% |
| Jun 30, 2025 | 3.20% |
| Mar 31, 2025 | -2.47% |
| Dec 31, 2024 | 11.78% |
| Sep 30, 2024 | 11.54% |
| Jun 30, 2024 | 17.02% |
| Mar 31, 2024 | 12.79% |
| Dec 31, 2023 | 8.96% |
| Sep 30, 2023 | 26.70% |
| Jun 30, 2023 | -3.01% |
| Mar 31, 2023 | 4.36% |
| Dec 31, 2022 | 7.74% |
| Sep 30, 2022 | -11.30% |
| Jun 30, 2022 | -29.45% |
| Mar 31, 2022 | -9.38% |
| Dec 31, 2021 | -60.48% |
| Sep 30, 2021 | -69.09% |
| Jun 30, 2021 | -18.36% |